Feb 25 (Reuters) - Private equity group EQT said on Wednesday it had decided not to proceed with a takeover offer for Oxford Biomedica, sending the British cell and gene therapy manufacturer's shares
EQT Walks Away From Takeover Bid for UK’s Oxford Biomedica plc
Decision Announced on Feb 25, 2026
EQT Ends Oxford Biomedica Takeover Talks
Feb 25 (Reuters) - Private equity group EQT said on Wednesday it had decided not to proceed with a takeover offer for Oxford Biomedica, sending the British cell and gene therapy manufacturer's shares down nearly 10%.
Byline and Attribution
(Reporting by Ankita Bora in Bengaluru; Editing by Shreya Biswas)


